Business

Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023

Conference Call and Webcast to Follow WASHINGTON, July 20, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will

articleVanda Pharmaceuticals Inc.July 20, 20233/company/vanda-pharmaceuticals-inc/news/vanda-pharmaceuticals-to-announce-second-quarter-2023-financial-results-on-july-27
Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023

About this update from Vanda Pharmaceuticals Inc.

[{"type":"text","content":"Conference Call and Webcast to Follow\nWASHINGTON, July 20, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2023 on Thursday, July 27, 2023, after the market closes. \n\n \n \n \n \n \n \n\n \nVanda will host a conference call at 4:30 PM ET on Thursday, July 27, 2023, during which management will discuss the second quarter 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 4063687.\nThe conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.\nA replay of the call will be available on Thursday, July 27, 2023, beginning at 8:30 PM ET and will be accessible until Thursday, August 3, 2023, at 8:30 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 4063687.\nAbout Vanda Pharmaceuticals Inc.\nVanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.\nCorporate Contact:Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. 202-734-3400 [email protected] \nElizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. 202-734-3400 [email protected] \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2023-financial-results-on-july-27-2023-301882530.html\nSOURCE Vanda Pharmaceuticals Inc.","length":4162,"tagName":"div"}]

More updates from Vanda Pharmaceuticals Inc.